Literature DB >> 17628552

Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics.

Susannah Baruch1, David Kaufman, Kathy L Hudson.   

Abstract

OBJECTIVE: To better understand the current practices of IVF clinics regarding preimplantation genetic diagnosis (PGD) and explore the attitudes and opinions of clinic directors toward PGD.
DESIGN: On-line Survey of 415 assisted reproductive technology (ART) clinics in the United States. The Survey had a valid response rate of 45% (186 clinics).
SETTING: Not applicable. PATIENT(S): Respondents were medical directors, laboratory directors, IVF directors, or directors' designees of ART clinics offering IVF. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Practices and beliefs of IVF clinic directors with respect to PGD. RESULT(S): Preimplantation genetic diagnosis is widely provided for a variety of indications, and clinic directors support professional guidelines to guide PGD in the future. CONCLUSION(S): Preimplantation genetic diagnosis is an established technology and medical procedure offered by a majority of US IVF clinics. Many clinics currently provide PGD for controversial indications such as sex selection. Although there is little support for government regulation of PGD, there is significant support among IVF clinics for strong professional guidelines for PGD practice. Ongoing collection of data on PGD practice and outcomes would help patients make informed decisions and aid professionals in developing appropriate guidelines and standards.

Entities:  

Mesh:

Year:  2007        PMID: 17628552     DOI: 10.1016/j.fertnstert.2007.05.048

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  28 in total

1.  Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.

Authors:  Pnina Mor; Sarah Brennenstuhl; Kelly A Metcalfe
Journal:  J Genet Couns       Date:  2018-06-01       Impact factor: 2.537

2.  Reproductive liberty and deafness: Clause 14(4)(9) of embryo bill should be amended or deleted.

Authors:  Steve Emery; Teresa Blankmeyer Burke; Anna Middleton; Rachel Belk; Graham Turner
Journal:  BMJ       Date:  2008-05-03

3.  The ethics of nonmedical sex selection.

Authors:  H Strange; R Chadwick
Journal:  Health Care Anal       Date:  2010-09

Review 4.  Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?

Authors:  Kim Dao Ly; Ashok Agarwal; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2011-07-09       Impact factor: 3.412

5.  Views of internists towards uses of PGD.

Authors:  Robert Klitzman; Wendy Chung; Karen Marder; Anita Shanmugham; Lisa J Chin; Meredith Stark; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  Reprod Biomed Online       Date:  2012-11-21       Impact factor: 3.828

6.  Public perspectives on the use of preimplantation genetic diagnosis.

Authors:  William D Winkelman; Stacey A Missmer; Dale Myers; Elizabeth S Ginsburg
Journal:  J Assist Reprod Genet       Date:  2015-03-11       Impact factor: 3.412

7.  Sex selection for non-medical indications: a survey of current pre-implantation genetic screening practices among U.S. ART clinics.

Authors:  Sarah M Capelouto; Sydney R Archer; Jerrine R Morris; Jennifer F Kawwass; Heather S Hipp
Journal:  J Assist Reprod Genet       Date:  2017-10-28       Impact factor: 3.412

8.  Preimplantation genetic diagnosis for stargardt disease.

Authors:  Mahsa A Sohrab; Rando Allikmets; Michael M Guarnaccia; R Theodore Smith
Journal:  Am J Ophthalmol       Date:  2010-02-10       Impact factor: 5.258

Review 9.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

10.  Views of preimplantation genetic diagnosis among psychiatrists and neurologists.

Authors:  Robert Klitzman; Kristopher J Abbate; Wendy K Chung; Ruth Ottman; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  J Reprod Med       Date:  2014 Jul-Aug       Impact factor: 0.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.